No preliminary studies have yet been performed on VS on the granulocyte-macrophage colony-stimulating factor (GM-CSF), which can have anti- or pro-tumorigenic effects depending on its expression and tumor immune microenvironment [16,17]. The gene discussed is CSF2; the disease is neoplasm.